Clinical Study
Ruxolitinib for Therapy of Graft-versus-Host Disease
Table 2
GvHD at ruxolitinib initiation, indication for ruxolitinib, diarrhea, and outcome of GvHD. CNI: calcineurin-inhibitor.
| | Patient | GvHD-control at
initiation of ruxolitinib | Indication for
ruxolitinib | Diarrhea at
ruxolitinib initiation | Response of GvHD
to ruxolitinib |
| | #1 | Controlled | (i) CNI-replacement
(ii) Steroid sparing | None | Yes | | #2 | Uncontrolled | (i) Uncontrolled GvHD | Severe | No | | #3 | Partially controlled | (i) CNI-replacement
(ii) Steroid-sparing | None | Yes | | #4 | Uncontrolled | (i) Uncontrolled GvHD | Severe | No | | #5 | Uncontrolled | (i) Uncontrolled GvHD | Severe | No | | #6 | Partially controlled | (i) Steroid sparing | None | Yes | | #7 | Partially controlled | (i) Steroid sparing | None | Yes | | #8 | Uncontrolled | (i) Uncontrolled GvHD | Severe | No |
|
|
